ZBRA EBITDA Growth
18.78%TTM
Period ending:
ZBRA TTM EBITDA YoY %%
835.31%-254.67%
1991-12-312026-07-04
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
ZBRA ebitda growth history
Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 139 observations from Dec 31, 1991 to Jul 4, 2026.
| Period ending | EBITDA Growth |
|---|---|
| 18.7822% | |
| 1.6598% | |
| 0.1055% | |
| 61.9482% | |
| 107.0513% | |
| 93.5743% | |
| 72.0508% | |
| -22.7967% | |
| -56.4651% | |
| -56.239% | |
| -51.6667% | |
| -22.2121% | |
| -4.4444% | |
| 1.0657% | |
| -2.9787% | |
| -6.4157% | |
| 6.032% | |
| 22.7917% | |
| 48.7342% | |
| 57.3351% | |
| 34.134% | |
| 7.8824% | |
| -8.3527% | |
| -14.9886% | |
| -6.8316% | |
| 5.5901% | |
| 9.1139% | |
| 17.7898% | |
| 22.6879% | |
| 22.5266% | |
| 36.6782% | |
| 39.212% | |
| 62.4413% | |
| 69.3299% | |
| 57.0652% | |
| 61.1772% | |
| 11.9015% | |
| 5.8109% | |
| 4.637% | |
| 61.9983% | |
| 174.0862% | |
| 266.747% | |
| 292.7282% | |
| 2.0711% | |
| -37.3458% | |
| -56.0689% | |
| -55.876% | |
| 3.7481% | |
| 15.0433% | |
| 17.6731% | |
| -0.3721% | |
| -2.8466% | |
| -2.7112% | |
| -5.3322% | |
| -2.1866% | |
| -5.4838% | |
| -2.3791% | |
| 7.2343% | |
| 15.1494% | |
| 24.5164% | |
| 37.276% | |
| 45.4993% | |
| 60.2745% | |
| 48.8391% | |
| 4.9328% | |
| -19.9647% | |
| -39.856% | |
| -41.704% | |
| -23.2301% | |
| -7.7448% | |
| 9.1235% | |
| 23.1111% | |
| 80.5375% | |
| 72.6345% | |
| 78.1477% | |
| 46.4267% | |
| -36.9519% | |
| -35.153% | |
| -40.695% | |
| -36.7662% | |
| -9.0879% | |
| -14.3104% | |
| -13.2064% | |
| -2.0193% | |
| 9.109% | |
| 22.6446% | |
| 32.5154% | |
| 26.0248% | |
| 21.9093% | |
| 18.0361% | |
| 22.5131% | |
| 25.6451% | |
| 26.2478% | |
| 25.4889% | |
| 6.1748% | |
| -2.1307% | |
| -16.9659% | |
| -23.3297% | |
| -17.0789% | |
| -16.3922% |
Compare ebitda growth
All ZBRA financial metrics · ZBRA stock overview · How to interpret financial metrics
